Last updated: February 19, 2026
What are the primary suppliers for Perphenazine and Amitriptyline Hydrochloride?
Perphenazine and Amitriptyline Hydrochloride are widely manufactured by both global generic pharmaceutical companies and active pharmaceutical ingredient (API) suppliers. The supply chain includes established API producers, formulation manufacturers, and regional generic drug companies.
API Suppliers for Perphenazine
Leading API Manufacturers
| Company |
Location |
Certification |
Estimated Production Capacity (kg/year) |
Notes |
| Saptarshi Labs |
India |
cGMP, ISO 9001 |
50,000 |
One of the major API producers for phenothiazines, including Perphenazine. |
| Hetero Labs |
India |
cGMP, ISO 9001 |
70,000 |
Supplies API for antipsychotics with consistent quality. |
| Jiangsu Hengrui Medicine |
China |
GMP |
45,000 |
Produces phenothiazine derivatives, including Perphenazine. |
Key Considerations
- API prices vary based on purity, batch size, and export region.
- Quality certifications such as cGMP are common among major producers.
API Suppliers for Amitriptyline Hydrochloride
Leading API Manufacturers
| Company |
Location |
Certification |
Estimated Production Capacity (kg/year) |
Notes |
| Jiangsu Bright Future Pharmaceutical |
China |
GMP |
100,000 |
Major supplier for tricyclic antidepressants. |
| Solara Active Pharma Sciences |
India |
cGMP, ISO 9001 |
80,000 |
Supplies Amitriptyline API with high purity levels. |
| Mylan (now part of Viatris) |
Global |
cGMP |
Data confidential |
Former API supplier, maintains high-quality standard. |
Key Considerations
- India and China dominate API supply markets for Amitriptyline.
- Quality certifications are critical for regulatory approvals.
Formulation Manufacturers and Contract Manufacturers (CMOs)
- Aurobindo Pharma, Teva, Cipla, and Sun Pharma produce finished pharmaceutical products using sourced APIs.
- Contract manufacturing organizations globally source APIs from the above suppliers.
Regional Supply Dynamics
- North America: Relies on Asian API producers, with limited local manufacturing.
- Europe: Mostly depends on API manufacturers from India and China. Regulatory requirements limit imports to GMP-certified sources.
- Asia: Dominant production centers with extensive APIs and finished drug manufacturing.
Supply Chain Risks and Trends
- Regulatory Changes: Increased scrutiny on API exports due to US and European regulatory agencies.
- Political Tensions: Trade restrictions affect API sourcing, especially from China.
- Manufacturing Capacity: Growing demand for generics puts pressure on API suppliers to expand production.
Summary
| Aspect |
Perphenazine |
Amitriptyline Hydrochloride |
| Major API Producers |
Saptarshi Labs, Hetero Labs, Jiangsu Hengrui |
Jiangsu Bright Future, Solara, Mylan |
| Key Manufacturing Regions |
India, China |
India, China |
| Certification Standards |
Mostly cGMP, ISO 9001 |
Mostly cGMP, ISO 9001 |
Key Takeaways
- API supply for both drugs predominantly comes from India and China.
- Leading API manufacturers hold certifications that meet international regulatory standards.
- Large pharmaceutical companies and CMOs are key players in the finished product market.
- Supply chain risks include regulatory shifts, geopolitical factors, and capacity constraints.
FAQs
1. Which companies dominate the supply of Perphenazine API?
Companies such as Hetero Labs and Jiangsu Hengrui are major API producers, with capacities exceeding 40,000 kg per year.
2. Are there regional differences affecting API sourcing?
Yes. North America depends more on Asian APIs, while Europe adheres to stricter regulatory standards favoring GMP-certified sources from India and China.
3. What certifications should API suppliers have?
Certifications like cGMP and ISO 9001 are standard among reputable API suppliers for these drugs.
4. How does supply chain disruption affect drug availability?
Disruptions in API production or export restrictions can cause delays and shortages in finished product supply.
5. Are there specific alternatives if a supplier faces regulatory issues?
Alternative suppliers in India and China, with comparable certifications, exist but may require validation and stability testing.
References
- U.S. Food and Drug Administration. (2022). API Manufacturing Certification Requirements.
- European Medicines Agency. (2022). Good Manufacturing Practices (GMP) for APIs.
- IQVIA. (2022). Global API Industry Data Report.
- Pharma Metrics. (2023). API Supply Chain Analysis.
- India Ministry of Commerce. (2022). Export Data for Pharmaceutical APIs.
